These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7240945)
1. Calcium flux antagonists: a new treatment for some patients with angina pectoris? Wise JR J Maine Med Assoc; 1980 Aug; 71(8):231. PubMed ID: 7240945 [No Abstract] [Full Text] [Related]
5. Vasodilators for angina pectoris. Drug Ther Bull; 1981 May; 19(10):37-9. PubMed ID: 6785060 [No Abstract] [Full Text] [Related]
6. [Treatment of angina pectoris (III)]. Breithaupt H; Walter P Med Welt; 1979 Feb; 30(7):233-7. PubMed ID: 372731 [No Abstract] [Full Text] [Related]
7. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation]. Pimenov LT; Ezhov AV; Churshin AD Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289 [No Abstract] [Full Text] [Related]
8. ACTION results of nifedipine in stable angina due next year. Cardiovasc J S Afr; 2003; 14(5):283. PubMed ID: 14664233 [No Abstract] [Full Text] [Related]
9. [Clinical experience with nifedipine in the treatment of angina pectoris in Japan]. Hosoda S Drugs; 2006; 66 Spec No 1():4-6. PubMed ID: 18200770 [TBL] [Abstract][Full Text] [Related]
10. Interpreting the ACTION study - benefits in patients with stable angina and raised blood pressure. Cardiovasc J S Afr; 2005; 16(1):58-60. PubMed ID: 15778776 [No Abstract] [Full Text] [Related]
11. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine. Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181 [TBL] [Abstract][Full Text] [Related]
12. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome. Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J; J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970 [TBL] [Abstract][Full Text] [Related]
13. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 8. Angina pectoris agents with effect on calcium metabolism]. Lumholtz IB Sygeplejersken; 1980 Apr; 80(16):21. PubMed ID: 6902528 [No Abstract] [Full Text] [Related]
14. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 9. Angina pectoris agents with effect on calcium metabolism]. Lumholtz IB Sygeplejersken; 1980 May; 80(18):29. PubMed ID: 6902540 [No Abstract] [Full Text] [Related]
15. [Characteristics of angina pectoris therapy with nitrates]. Silber S Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920 [TBL] [Abstract][Full Text] [Related]
16. [Clinical observation on treatment of 45 angina pectoris patients of coronary heart disease with taponin]. Liu KY; Zhang Y; Feng ZX Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Nov; 15(11):649-51. PubMed ID: 8732147 [TBL] [Abstract][Full Text] [Related]
17. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. Other angina pectoris agents]. Lumholtz IB Sygeplejersken; 1980 May; 80(20):23. PubMed ID: 6902553 [No Abstract] [Full Text] [Related]
18. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina. Toal CB; Motro M; Baird MG; Klinke P; Sclarowski S; Zilberman A; Marmor A; Kostuk WJ; Lotan C; Weiss A; Erne P; Palant A; Stolero D; Bélanger L; Turpie A Can J Cardiol; 1999 Oct; 15(10):1103-9. PubMed ID: 10523477 [TBL] [Abstract][Full Text] [Related]
19. [S-4004, a new preparation in the treatment of angina pectoris. A clinical assessment by double-blind trial]. Nyfors A Ugeskr Laeger; 1967 Aug; 129(33):1059-61. PubMed ID: 4877700 [No Abstract] [Full Text] [Related]